Cordica Medical acquires RapidWerks micro-molding capability

NEWS RELEASE: Cordica Medical acquires RapidWerks micro-molding Expanding Cordica Medical’s precision capabilities for the miniaturization of next-generation medical devices KNOXVILLE, Tenn. — Cordica Medical (Cordica), a medical device contract development and manufacturing organization (CDMO), announced that it has acquired RapidWerks’ micro-molding capabilities. The acquisition adds dedicated, fully automated micro-molding for mass production to Cordica’s integrated design…

The post Cordica Medical acquires RapidWerks micro-molding capability appeared first on Medical Design and Outsourcing.

Solventum executive pay disclosure includes $11M severance for ex-MedSurg leader

Solventum recently reported compensation for its top executives and median employee for its first full year as a standalone company. The business formerly known as 3M Health Care spun off from 3M and became an independently publicly traded company on April 1, 2024. As part of the move, some Solventum executives received hiring bonuses, make-whole…

The post Solventum executive pay disclosure includes $11M severance for ex-MedSurg leader appeared first on Medical Design and Outsourcing.

Researchers say microrobots can deliver stem cells to treat spinal cord injuries

Researchers in Zurich say they have developed a method to use microrobots delivering stem cell therapies to treat spinal cord injuries. According to ETH Zurich and the University of Zurich (UZH), modern therapies for spinal cord injuries attempt to influence implanted stem cells using electrical stimulation, promoting the growth of new nerve cells. However, researchers…

The post Researchers say microrobots can deliver stem cells to treat spinal cord injuries appeared first on Medical Design and Outsourcing.

Opinion: How the Amish think about vaccines, health care costs, and much more

Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Cory Anderson and Braxton Mitchell. Be sure to sign up for the weekly “First Opinion Podcast” on Apple PodcastsSpotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t forget to sign up for the First Opinion newsletter, delivered every Sunday.

Torie Bosch: Last fall, there was a flurry of interest in the Amish and health after President Trump repeated a common claim among vaccine critics: that the Amish don’t vaccinate and don’t get autism. It’s much more complicated than that, though — and it’s far from the only interesting and consequential question about the Amish and public health.

Read the rest…

Opinion: I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous action

By the time the world began responding to the West Africa epidemic in 2014, which killed more than 11,000 people before it ended in 2016, there were 40 to 50 suspected cases.

The current outbreak in the Democratic Republic of the Congo had approximately 10 times that number by the time the response started. Three weeks in, it has spread from three health zones to 25, with new areas added almost daily. National, provincial, and local health staff are responding intensively, but fewer than half of known contacts are being traced nationwide, laboratories are backlogged, no Ebola treatment center is ready, few health workers have been trained, there’s insufficient protective equipment for health workers and few medications for patients, and burial teams have come under attack.

Read the rest…

Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial

Nature Medicine, Published online: 05 June 2026; doi:10.1038/s41591-026-04476-6

As presented at the American Diabetes Association Meeting: this randomized phase 2b trial in 230 adults with overweight or obesity shows that aleniglipron, an oral small-molecule GLP1-RA, led to up to 11.3% body-weight loss compared with placebo after 36 weeks of treatment.

CDC: Ebola outbreak in Central Africa could reach 20,000 cases without strong countermeasures

NEW YORK — The Ebola outbreak in Central Africa could grow to 20,000 cases or more, depending on how quickly infected people are isolated to slow the spread, according to a new analysis by U.S. health officials.

The Centers for Disease Control and Prevention published a range of scenarios generated by computer models Friday, spanning from 10,000 cases to more than 20,000. If accurate, a worst-case scenario could approach the worst Ebola outbreak in history, the West Africa epidemic in 2014-2016 — which resulted in more than 28,000 reported cases and more than 11,000 deaths.

Read the rest…

STAT+: Newer GLP-1s, pushback on research cuts, and a protest 

You’re reading the web edition of STAT’s ADA in 30 Seconds newsletter from the American Diabetes Association’s annual conference. Sign up here

This is Elizabeth Cooney saying hello from New Orleans, where the weather is warm, the conference center is cool, and debates can be fiery. Welcome to the first of three ADA in 30 newsletters, in which my colleague Elaine Chen and I curate some of the news and analyses circulating here near the banks of the mighty Mississippi.

First up, thoughts from Rick Woychik, a senior adviser to NIH chief Jay Bhattacharya who subbed for him as keynote speaker, plus some background from our STAT colleague Anil Oza. Then, what the weekend will bring.

If you are here too, come say Hi, or reach me at elizabeth.cooney@statnews.com.

Continue to STAT+ to read the full story…

Evaluating an Abbreviated Internet-Delivered Stress Recovery Intervention for Health Care Workers: Pre-Post Feasibility Study of Outcomes, Usability, and Acceptability

<strong>Background:</strong> Health care workers face numerous occupational stressors that place them at heightened risk for burnout and poor mental health. Internet-delivered interventions have shown promise in reducing stress and related symptoms, yet adherence is often low, and users do not complete programs. Abbreviated interventions may help address engagement barriers such as high workload, limited time, and varying user preferences. There is a need to evaluate brief, accessible formats of internet-delivered programs for this population. <strong>Objective:</strong> This study aimed to examine the initial outcomes, usability, and acceptability of a 4-week abbreviated internet-delivered stress recovery intervention for health care workers. Specifically, it evaluated changes in stress recovery, perceived stress, depression and anxiety symptoms, and psychological well-being. The study also sought to understand participants’ experiences with the brief format to determine whether it meets their needs. <strong>Methods:</strong> This single-arm pre-post study examined a 4-week abbreviated version of the online guided cognitive behavioral therapy-based stress recovery program FOREST among self-enrolled health care workers recruited through professional networks (N=52; mean age 39.31, SD 11.31 years; 49/52, 94.2% women). Outcomes included stress recovery (the Recovery Experience Questionnaire), perceived stress (the Perceived Stress Scale-4), depression and anxiety symptoms (the Patient Health Questionnaire-4), psychological well-being (the World Health Organization Well-being Index), and usability and acceptability ratings. <strong>Results:</strong> We found that after the abbreviated version of the FOREST intervention participants showed moderate improvements in stress recovery (<i>d</i>=0.54, 95% CI 0.25-0.83); reductions in stress (<i>d</i>=–0.43, 95% CI –0.72 to –0.14), anxiety and depression symptoms (<i>d</i>=–0.51, 95% CI –0.80 to –0.22); and increase in psychological well-being (<i>d</i>=0.39, 95% CI 0.08-0.70). The majority (37/52, 71.2%) accessed all 6 modules. Users reported high satisfaction with the abbreviated program. <strong>Conclusions:</strong> While preliminary and limited by the pre-post design, these findings indicate that abbreviated internet-based stress recovery programs are a promising and practical tool for supporting the mental health of health care workers. Future research should examine the long-term effects, compare the abbreviated and standard versions, and explore implementation in routine practice. <strong>Trial Registration:</strong>